“Lilly Warns Patients About Counterfeit and Compounded Medicines Releases Open Letter and Takes Further Legal Action Against Counterfeit, Fake, Unsafe, and Untested Products”
The FDA published its annual drug shortage report for 2023, CBP in Cincinnati seized multiple shipments of fake Ozempic, and international counterfeit medicine stories out of six different countries.
PSM submitted a letter to leaders in the New York State legislature opposing a legislative proposal (AB 7954) to setup a wholesale Canadian drug importation program. The bill died right before end of session.
PSM and ADAP Advocacy launched a campaign today about the dangers of medicine diversion criminals operating on gay dating apps such as Grindr. Learn more and report the crime on our campaign page.
The CAST Act introduced in the Senate. More lawsuits against copycat Wegovy sellers. Pill presses seized in multiple countries. Read about these and other stories in our weekly counterfeit medicine news roundup.
A Colorado board is considering setting a price limit on the medicine Stelara. This will have unintended consequences, undermining the safety of the supply chain for this medicine and limiting patient access. Learn more by reading our testimony.
Executive Director Shabbir Safdar’s editorial ran on May 15, 2024 in Colorado Politics
States like Colorado are experimenting with Prescription Drug Affordability Boards to address the price of medicine, but solutions like Upper Payment Limits will yield multiple unintended consequences that will do more harm than good to patients.
The operator of Incognito is charged with engaging in a continuing criminal enterprise, narcotics conspiracy, money laundering and conspiracy to sell adulterated and misbranded medication.
PSM is launching a public awareness campaign about the dangers of fake Botox. The campaign includes a dozen slides with quotes from a fake Botox victim about her physical effects. You can view the campaign elements in the gallery below or on PSM’s instagram channel as it rolls out over the next few weeks.